Across TCGA pan-cancer cohorts, CT47A12 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated CT47A12 data layer.
The strongest signal is observed in esophageal carcinoma (ESCA), where higher CT47A12 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CT47A12 expression acts as an unfavorable survival marker.
ESCA are the cancer types where CT47A12 RNA most reproducibly stratifies survival.